 Bayesian predictive monitoring with bivariate binary outcomes in phase II clinical trialsValeria Sambucini Computational Statistics & Data Analysis, 2019, vol. 132, issue C, 18-30 Abstract: Traditionally, phase II single-arm trials are based on a binary response variable that represents the efficacy of the experimental treatment. However, the introduction of an additional binary endpoint to assess whether the new therapy is also sufficiently safe for a further evaluation in larger phase III studies is often suggested. A Bayesian predictive strategy for interim monitoring in phase II trials focused on bivariate binary outcomes is proposed. At any interim analysis, the stopping rules are based on the evaluation of the predictive probability that the trial will show a conclusive result at the planned end of the study, given the observed data. The proposed procedure is applied using hypothetical scenarios that represent different situations which may occur at the interim stage. A real data application is also illustrated with the use of both non-informative and informative prior distributions. Finally, simulation studies to evaluate the operating characteristics of the design have been performed. Keywords: Bayesian monitoring; Dirichlet-multinomial model; Efficacy and safety endpoints; Posterior predictive probabilities; Phase II clinical trials (search for similar items in EconPapers) Downloads: (external link) Related works: Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text Persistent link: https://EconPapers.repec.org/RePEc:eee:csdana:v:132:y:2019:i:c:p:18-30 DOI: 10.1016/j.csda.2018.06.015 Access Statistics for this article Computational Statistics & Data Analysis is currently edited by S.P. Azen More articles in Computational Statistics & Data Analysis from Elsevier |
Is your work missing from RePEc? Here is how to contribute.
Questions or problems? Check the EconPapers FAQ or send mail to .
EconPapers is hosted by the
School of Business at Örebro University.